INNOVA CAPTAB LIMITED (MAINBOARD)
Dec 21, 2023 - Dec 26, 2023
| Price | ₹426 - ₹448 |
| Premium | ₹32 |
|---|---|
| Lot size | 33 |
| Allotment | Dec 27, 2023 |
| Listing | Dec 29, 2023 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 33 | 14784 | 134943 |
| sHNI | 14 | 462 | 206976 | 1377 |
| bHNI | 68 | 2244 | 1005312 | 2754 |
Last Updated as on 26-Dec-2023 17:54:00
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 2544643 | 295557042 | 116.15 |
| HNIs | 1908483 | 127536618 | 66.83 |
| HNIs (10+L) | 1272322 | 93727524 | 73.67 |
| HNIs (2-10L) | 636161 | 33809094 | 53.15 |
| Retail | 4453125 | 78565872 | 17.64 |
| Total | 8906251 | 501659532 | 56.33 |
| Total Application : 2,392,355 | |||
| QIB Cost (7 Days) per share | |||||
|---|---|---|---|---|---|
| @7% ₹69.86 | @8% ₹79.83 | @9% ₹89.81 | @10% ₹99.79 | @11% ₹109.77 | @12% ₹119.75 |
Incorporated in January 2005, Innova Captab Limited is a pharmaceutical company operating in three business segments. Firstly, it provides contract development and manufacturing services to Indian pharmaceutical companies. Secondly, the company has a domestic business dealing in branded generics. And thirdly, the company has an international business that deals in branded generics.
The company's product portfolio includes tablets, capsules, dry syrups, dry powder injections, ointments and liquid medicines.
In the financial year 2023 and the three months ended June 30, 2023, the company produced and sold more than 600 different types of generics. These products were distributed under the company's own brands in the Indian market through a network of approximately 5,000 distributors and stockists and over 150,000 retail pharmacies. In addition, Innova Capitab exported its branded generic products to 20 and 16 countries in FY2023 and the three months ended June 30, 2023, respectively.
As of October 31, 2023, the company employed a team of 29 scientists and engineers in its research and development laboratory. The company's manufacturing facility is located in Buddi, Haryana
The company's customer base includes Cipla Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited, Corona Remedies Private Limited, Emcure Pharmaceuticals Limited, Lupin Limited, Intas Pharmaceuticals Limited, Leeford Healthcare Limited, Medley Pharmaceuticals Limited, Cachet Pharmaceuticals Limited, Eris Healthcare Private Limited, Indoco Remedies Limited, J. B. Chemicals and Pharmaceuticals Limited, Oaknet Healthcare Private Limited, Zuventus Healthcare Limited, Ajanta Pharma Limited, Mankind Pharma Limited and Smart Laboratories Private Limited.
As of October 31, 2023, the company has 200 active product registrations and 20 registrations pending renewal with international authorities. In addition, 218 new registration applications are being processed with international authorities.
Innova Captab IPO Details
| Issue Size | [.] shares (aggregating up to ₹570.00 Cr) |
| Fresh Issue | [.] shares (aggregating up to ₹320.00 Cr) |
| Offer for Sale | 5,580,357 shares of ₹10 (aggregating up to ₹250.00 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 50,082,072 |
Innova Captab IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Company Financials
Innova Captab Limited Financial Information (Restated Consolidated)
Innova Captab Limited's revenue increased by 16.45% and profit after tax (PAT) rose by 6.26% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period | 30 Jun 2023 | Mar 2023 | Mar 2022 | Mar 2021 |
| Assets | 1,086.16 | 704.41 | 575.48 | 369.62 |
| Revenue | 234.37 | 935.58 | 803.41 | 412.03 |
| Profit | 17.59 | 67.95 | 63.95 | 34.50 |
| Net Worth | 294.27 | 276.46 | 208.56 | 144.78 |
| Reserves | 228.51 | 67.90 | 196.61 | 132.82 |
| Borrowing | 441.90 | 235.19 | 198.18 | 45.03 |
| Amount in ₹ Crore | ||||
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: innovacaptab.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/